Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...

A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...

Novo Nordisk and Eli Lilly's motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form ...

Josh Gad says he's taking 'life-changing' GLP-1 medication for weight loss but admits that it can't replace having a healthy ...

Nick Kaye, chairman of the NPA, told the PA news agency: “It is important that consultations with patients are thorough, ...

The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

Loose Women star Brenda Edwards has revealed the truth behind her jaw-dropping weight loss after dropping three dress sizes ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

If you've been scrolling through TikTok recently, you might have come across the "winter arc" trend — a sort of fresh take on ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules to be introduced around sale of weight loss jabs online.

It's calling for tougher rules around online sales of drugs like Ozempic, urging regulator the General Pharmaceutical Council ...

The rise of ultra-thin bodies in Hollywood, fueled by the popularity of weight loss medications, marks a dramatic shift in ...